Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma

1. San Miguel, J.F.
2. Weisel, K.C.
3. Song, K.W.
4. Delforge, M.
5. Karlin, L.
6. Goldschmidt, H.
7. Moreau, P.
8. Banos, A.
9. Oriol, A.
10. Garderet, L.
11. Cavo, M.
12. Ivanova, V.
13. Alegre, A.
14. Martinez-Lopez, J.
15. Chen, C.
16. Renner, C.
17. Bahlis, N.J.
18. Yu, X.
19. Teasdale, T.
20. Sternas, L.
21. Jacques, C.
22. Zaki, M.H.
23. Dimopoulos, M.A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.2015.125864 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus